NFKBIA and liver cancer: Whereas inhibition of NFκB by an IκBα super-repressor can impede tumor progression in MDR2 knock-out mice, which develop liver cancer as a result of chronic cholangitis6, a complete loss of the central NFκB activator IKKγ/NEMO in hepatocytes leads to spontaneous liver cancer development7.